Bolt Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.41

+0.37 (+9.16%)

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 64%

Hold 4 36%

Sell 0 0%

Price Target

Analyst Price Target +498.0% upside

Low Target $21.16

Average Target $26.37

High Target $30.50

Current Price $4.41

Current
$4.41

Target
$26.37

$21.16 $26.37 avg $30.50

Scenario Analysis

Bear Case

$21.16

379.8%

Low target

Base Case

$26.37

+498.0%

Avg target

Bull Case

$30.50

+591.6%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$9.38

-53.0% from high

52-Week Low

$3.91

+12.8% from low

Target vs 52W High

$26.37

+181.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%